Column Group IV GP, LP — SEC Form 4 filings
SEC reporting owner CIK 1796356. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-04-08 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 2,206,960 shares, $39,150,725 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: purchase of 1,437,323 shares @ $18.00 ($25,871,814) in Eikon Therapeutics, Inc., filed 2026-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 2 | 4 legs · 2,206,960 sh · $39,150,725 | — | 14 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 1 | — | — | 14 |
| RAPT Therapeutics, Inc. (RAPT) | 10% owner | 1 | — | — | 4 |
Form 4 filings — Column Group IV GP, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Purchase (P): 89,200 @ $11.56 | EDGAR |
| 2026-02-09 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2024-12-23 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796356 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →